All of DSpace

Browsing by Subject "Treatment Failure"

Now showing items 1-4 of 4

    • Artificial oocyte activation: physiological, pathophysiological and ethical aspects 

      Anifandis G., Michopoulos A., Daponte A., Chatzimeletiou K., Simopoulou M., Messini C.I., Polyzos N.P., Vassiou K., Dafopoulos K., Goulis D.G. (2019)
      Infertile couples with low oocyte yield in combination with abnormal semen parameters may experience intra-cytoplasmic sperm injection (ICSI) failure. An established factor associated with ICSI failure is oocyte activation ...

    • The choice of drainage device in complicated glaucomas: Comparing Ahmed and Baerveldt implants 

      Moschos M.M., Nitoda E., Gouliopoulos N., Androudi S., Damaskos C., Laios K., Bagkli E., Garmpis N., Kitsos G. (2019)
      Background/Aim: Glaucoma is a chronic and progressive optic neuropathy which leads to deterioration of visual function. It is estimated to be the second leading cause of severe vision loss and blindness worldwide. Failure ...

    • Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 

      Agrawal R., Gunasekeran D.V., Grant R., Agarwal A., Kon O.M., Nguyen Q.D., Pavesio C., Gupta V., Gupta B., Aggarwal K., Murthy S.L., Westcott M., Phaik C.S., McCluskey P., Ling H.S., Teoh S., Cimino L., Biswas J., Narain S., Agarwal M., Mahendradas P., Khairallah M., Jones N., Tugal-Tutkun I., Babu K., Basu S., Carreño E., Lee R., Al-Dhibi H., Bodaghi B., Invernizzi A., Goldstein D.A., Herbort C.P., Barisani T., González-López J.J., Androudi S., Bansal R., Moharana B., Mahajan S., Esposti S., Tasiopoulou A., Nadarajah S., Agarwal M., Abraham S., Vala R., Singh R., Sharma A., Sharma K., Zierhut M., Raje D., Cunningham E., Kempen J., Collaborative Ocular Tuberculosis Study (COTS)-1 Study Group (2017)
      IMPORTANCE Eradication of systemic tuberculosis (TB) has been limited by neglected populations and the HIV pandemic. Whereas ocular TB often presents as uveitis without any prior evidence of systemic TB, the existing ...

    • Longterm beneficial effect of canakinumab in colchicine-resistant familial mediterranean fever 

      Laskari K., Boura P., Dalekos G.N., Garyfallos A., Karokis D., Pikazis D., Settas L., Skarantavos G., Tsitsami E., Sfikakis P.P. (2017)
      Objective. To assess the efficacy and safety of the interleukin-1β (IL-1β) inhibitor canakinumab in all adolescent and adult patients with familial Mediterranean fever (FMF) identified from the Greek National Registry for ...